van HuisstedeA, Noordhoek HegtV, Otte-HollerI, Looijen-SalamonM, RudolphusA. Talcosis due to abundant use of cosmetic talcum powder. Eur Respir Rev, 2010; 19(116):165–168.
2.
PairaudeauPW, WilsonRG, HallMA, MilneM. Inhalation of baby powder: an unappreciated hazard. BMJ, 1991; 302(6786):1200–1201.
3.
DekelY, Rath-WolfsonL, RudnikiC, KorenR. Talc inhalation is a life-threatening condition. Pathol Oncol Res, 2004; 10(4):231–233.
SieniewiczDJ, NideckerAC. Conglomerate pulmonary disease: a form of talcosis in intravenous methadone abusers. AJR Am J Roentgenol, 1980; 135(4):697–702.
6.
WardS, HeynemanLE, ReittnerP, KazerooniEA, GodwinJD, MüllerNL. Talcosis associated with IV abuse of oral medications: CT findings. AJR Am J Roentgenol, 2000; 174(3):789–793.
7.
CardilloG, FaccioloF, CarboneL, RegalM, CorzaniF, RicciA, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg, 2002; 21(2):302–305; discussion 305-306.
8.
de CamposJR, VargasFS, de Campos WerebeE, CardosoP, TeixeiraLR, JateneFB, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest, 2001; 119(3):801–806.
AbrahamJL, BrambillaC. Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res, 1980; 21(1):94–96.
11.
GoldbachPD, MohsenifarZ, AbrahamJL, YoungWI, MerrillWD. Talcum powder pneumoconiosis: diagnosis by transbronchial biopsy using energy-dispersive x-ray analysis. West J Med, 1982; 136(5):439–442.
12.
RobertsWC. Pulmonary talc granulomas, pulmonary fibrosis, and pulmonary hypertension resulting from intravenous injection of talc-containing drugs intended for oral use. Proc (Bayl Univ Med Cent), 2002; 15(3):260–261.
13.
GriffithCC, RavalJS, NicholsL. Intravascular talcosis due to intravenous drug use is an underrecognized cause of pulmonary hypertension. Pulm Med, 2012; 2012:617531.
